Pioneering solutions, saving lives
Research is critical to combatting brain disease and improving the lives of those impacted, today and in the future.
Conducted by The Royal Melbourne Hospital’s Departments of Neurology and Neurosurgery, the active research programs and clinical trials supported by the Foundation cover an extensive breadth of neurological conditions.
Patients wishing to participate are encouraged to view the relevant trial and contact the trial co-ordinator for more information.
| Brain Tumour / Neurosurgery: | NsurgClerk@mh.org.au |
| Dementia: | DementiaTrials@mh.org.au |
| Epilepsy: | EpilepsyCoordinator@mh.org.au |
| Huntington’s Disease: | RMHHuntingtonDiseaseStudies@mh.org.au |
| Movement Disorders: | MovementDisorders@mh.org.au |
| Multiple Sclerosis: | MSClinic@mh.org.au |
| Neurophysiology: | RMH-ClinicalNeurophysiology@mh.org.au |
| Stroke: | RMH-StrokeResearchTeam@mh.org.au |
| General: | Neuro.Foundation@mh.org.au |
The molecular drivers of brain metastases
Supporting Liquid Biopsy for Glioma: A circulating molecular biomarker to diagnose and guide treatment for glioma patients via simple blood test over invasive surgery or tissue biopsies
Responding to need: technology-enhanced brain cancer survivorship – Phase 2
An adaptive, multi-domain platform of comprehensive translational and feasibility research to study the biology of brain and other central nervous system (CNS) cancers
A Phase 0/2 Study of AB-218 in Patients with IDH1 Mutated Low Grade Glioma